Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Bipolar Disorder
Interventions
DRUG

Licarbazepine

Trial Locations (22)

19124

Investigational Site, Philadelphia

21033

Investigational Site, Dijon

27609

Investigational Site, Raleigh

33952

Investigational Site, Port Charlotte

45267

Investigational Site, Cincinnati

46222

Investigational Site, Indianapolis

67091

Investigational Site, Strasbourg

67114

Investigational Site, Newton

72211

Investigational Site, Little Rock

73118

Investigational Site, Oklahoma City

77007

Investigational Site, Houston

77021

Investigational Site, Houston

77401

Investigational Site, Bellaire

78756

Investigational Site, Austin

89103

Investigational Site, Las Vegas

90703

Investigational Site, Cerritos

92126

Investigational Site, San Diego

98033

Investigational Site, Kirkland

107076

Investigational Site, Moscow

113152

Investigational Site, Moscow

123367

Investigational Site, Moscow

193019

Investigational Site, Saint Petersburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY